Tuesday, 9th August 2022
<To guardian.ng
Search

BioNTech wants to ‘eradicate’ malaria with mRNA vaccine

After developing a coronavirus vaccine in record time, the German pharmaceutical company aims to start trialing a malaria shot next year using the same breakthrough mRNA technology.

Related

6 May 2021
The FDA is expected to approve the BioNTech-Pfizer COVID-19 vaccine for adolescents between the ages of 12 and 15 next week, according to media reports. DW has the latest.
12 May 2021
The German-developed coronavirus vaccine has become the first to get the go ahead for use among children aged 12 and up.
13 May 2021
The CDC has given a green light to using the BioNTech-Pfizer vaccine in children aged 12 to 15. Meanwhile, Cuba has started inoculating its citizens using two locally produced vaccines. Follow DW for the latest.
10 Jun 2021
President Joe Biden is expected to make the announcement before the G7 summit kicks off. The donation comes as the US attempts to reclaim its role as a global leader after four years of isolationism.
25 Jun 2021
The US Centers for Disease Control and prevention have confirmed that myocarditis and pericarditis can occur after mRNA vaccination in young people. But the cases are rare. Medical experts still recommend the shots.
1 Jul 2021
China has become the 40th country to be declared malaria-free. An expert team traveled in May this year to verify China's malaria-free status. It has not had an indigenous case for four years.
13 Jul 2021
BioNTech and Pfizer said an extra dose of their jab could boost immunity against the coronavirus delta variant. South Korea raised pandemic restrictions as cases hit the "maximum crisis level." Follow DW for the latest.
23 Jul 2021
The Biovac Institute reached a deal with Pfizer to prepare and deliver vaccine doses for the continent. It comes amid an increase of cases in Africa, where just 2% of the population have received a first dose.
27 Jul 2021
After developing a coronavirus vaccine in record time, the German pharmaceutical company aims to start trialing a malaria shot next year using the same breakthrough mRNA technology.
13 Sep 2021
BioNTech wants to continue the success of its COVID-19 vaccine and use mRNA technology to develop shots against malaria. But is production in Africa realistic?
20 Sep 2021
The announcement comes as coronavirus cases among children surge in the United States and other parts of the world.
2 Oct 2021
The FDA's limited approval comes weeks after US President Joe Biden's administration announced a sweeping plan that would allow nearly all American adults to get a third shot.